Invitrx Therapeutics Revenue
Biotechnology Research • 
Lake Forest, California, United States • 21-50 Employees
Invitrx Therapeutics revenue & valuation
| Annual revenue | $34,300,000 |
| Revenue per employee | $1,180,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $109,500,000 |
| Total funding | No funding |
Key Contact at Invitrx Therapeutics
Cynthia Liting Lee
Director Of Operation
Company overview
| Headquarters | 20503 Crescent Bay Dr, Lake Forest, California 92630, US |
| Phone number | +19498563142 |
| Website | |
| SIC | 873 |
| Keywords | Adipose Derived Stem Cell Procedures, Patented Stem Cell Media Derived Cosmetic Line, Stem Cell Alternative Bone And Joint Surgeries, Post Surgery Healing Procedures |
| Founded | 2003 |
| Employees | 21-50 |
| Socials |
Invitrx Therapeutics Email Formats
Invitrx Therapeutics uses 4 email formats. The most common is {first initial} (e.g., j@invitrx.com), used 58.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@invitrx.com | 58.8% |
{first name} | john@invitrx.com | 23.5% |
{first name}{last name} | johndoe@invitrx.com | 11.8% |
{last name} | doe@invitrx.com | 5.9% |
About Invitrx Therapeutics
Invitrx Therapeutics, Inc. is a biotechnology company specializing in the culture and engineering of adult stem cells by which we develop innovative products and therapies that are used in aesthetics, wound closure, and healing as well as plastic and reconstructive surgery. Invitrx was founded in July 2003 by Habib Torfi following many years of research and clinical trials involving adult stem cell technology. The research was originally developed to treat patients suffering from burns, diabetic ulcers, ocular surface disorders, and other ophthalmic conditions. Methods were developed to harvest and concentrate stem cells, providing the bases for Invitrx's cytokine and growth factor technology that demonstrated remarkable results in anti-aging by reducing the appearance of blemishes, fine lines, and wrinkles. Thus, using Invitrx stem cell core technologies, the ReLuma skin, hair, and lash therapy product line was created. ReLuma cosmetic products were designed utilizing adult stem cell technology to rejuvenate and reactivate dormant cells. The entire line of ReLuma products, including hair care, are formulated with human adult stem cell conditioned media containing cytokines and growth factors (along with interleukins and matrix proteins) to help reduce signs of aging and promote a youthful, even-toned glow.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Invitrx Therapeutics has 7 employees across 6 departments.
Departments
Number of employees
Funding Data
Invitrx Therapeutics has never raised funding before.
Invitrx Therapeutics Tech Stack
Discover the technologies and tools that power Invitrx Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Video players
Analytics
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Programming languages
Security
Blogs
Analytics
Video players
United Kingdom
India
Spain
South Africa
Frequently asked questions
4.8
40,000 users
